海王生物(000078)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

000078 海王生物

已收盘 07-26 15:00:00

{"stockData":{"symbol":"000078","market":"SZ","secType":"STK","nameCN":"海王生物","latestPrice":2.55,"timestamp":1721977404000,"preClose":2.51,"halted":0,"volume":13972715,"delay":0,"floatShares":2626000000,"shares":2751000000,"eps":-0.626,"marketStatus":"已收盘","marketStatusCode":5,"change":0.04,"latestTime":"07-26 15:00:00","open":2.52,"high":2.55,"low":2.51,"amount":35393800,"amplitude":0.0159,"askPrice":2.55,"askSize":9225,"bidPrice":2.54,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.626,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722216600000},"adr":0,"adjPreClose":2.51,"symbolType":"stock","openAndCloseTimeList":[[1721957400000,1721964600000],[1721970000000,1721977200000]],"highLimit":2.76,"lowLimit":2.26,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2750833257,"pbRate":2.27,"roa":"--","roe":"1.41%","epsLYR":-0.6423,"committee":-0.201201,"marketValue":7015000000,"floatMarketCap":6696000000,"peRate":-4.073483,"changeRate":0.0159,"turnoverRate":0.0053,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-07-29。"},"requestUrl":"/m/hq/s/000078/wiki","defaultTab":"wiki","newsList":[{"id":"2454534903","title":"海王生物（000078）7月25日主力资金净买入424.43万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454534903","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454534903?lang=zh_cn&edition=full","pubTime":"2024-07-26 09:22","pubTimestamp":1721956963,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月25日收盘，海王生物报收于2.51元，下跌1.95%，换手率0.76%，成交量19.97万手，成交额5035.26万元。近5日资金流向一览见下表：海王生物融资融券信息显示，融资方面，当日融资买入205.65万元，融资偿还390.03万元，融资净偿还184.38万元。融券方面，融券卖出1000.0股，融券偿还2100.0股，融券余量41.48万股，融券余额104.11万元。海王生物主营业务：涵盖医药商业流通、医药制造、医药研发。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072600013937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000078","BK0060","BK0209","BK0188","BK0028","BK0168"],"gpt_icon":0},{"id":"2454382229","title":"海王生物：公司2022年度、2023年度研发投入金额分别为6371.41万元与6,259.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454382229","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454382229?lang=zh_cn&edition=full","pubTime":"2024-07-25 20:01","pubTimestamp":1721908897,"startTime":"0","endTime":"0","summary":"证券之星消息，海王生物(000078)07月25日在投资者关系平台上答复投资者关心的问题。投资者：请问贵司近两年在研发费用上为何不加大投入？不加大研发占比，怎么可持续提升营收和净利润？海王生物董秘：您好，感谢您的关注。公司2022年度、2023年度研发投入金额分别为6371.41万元与6,259.57万元。公司将根据在研药物的项目进展情况及时履行信息披露义务。谢谢！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072500041851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0188","000078","BK0168","BK0028","BK0060"],"gpt_icon":0},{"id":"2453207225","title":"海王生物（000078）7月19日主力资金净买入1449.54万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453207225","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453207225?lang=zh_cn&edition=full","pubTime":"2024-07-22 09:11","pubTimestamp":1721610710,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月19日收盘，海王生物报收于2.69元，上涨5.91%，换手率2.08%，成交量54.63万手，成交额1.43亿元。近5日资金流向一览见下表：海王生物融资融券信息显示，融资方面，当日融资买入846.06万元，融资偿还1176.35万元，融资净偿还330.29万元。融券方面，融券卖出0.0股，融券偿还0.0股，融券余量41.59万股，融券余额111.88万元。海王生物主营业务：涵盖医药商业流通、医药制造、医药研发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200002397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0209","BK0188","000078","BK0168","BK0060"],"gpt_icon":0},{"id":"2452818975","title":"海王生物（000078）7月16日主力资金净买入2310.60万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452818975","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452818975?lang=zh_cn&edition=full","pubTime":"2024-07-17 09:11","pubTimestamp":1721178707,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月16日收盘，海王生物报收于2.41元，上涨6.17%，换手率2.02%，成交量53.06万手，成交额1.26亿元。近5日资金流向一览见下表：海王生物融资融券信息显示，融资方面，当日融资买入1066.39万元，融资偿还369.28万元，融资净买入697.11万元，连续3日净买入累计972.21万元。海王生物主营业务：涵盖医药商业流通、医药制造、医药研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700014923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0060","BK0188","BK0028","BK0168","000078"],"gpt_icon":0},{"id":"2451985798","title":"海王生物（000078）7月15日主力资金净买入1046.13万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451985798","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451985798?lang=zh_cn&edition=full","pubTime":"2024-07-16 09:01","pubTimestamp":1721091679,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月15日收盘，海王生物报收于2.27元，上涨4.13%，换手率1.14%，成交量30.05万手，成交额6746.96万元。近5日资金流向一览见下表：海王生物融资融券信息显示，融资方面，当日融资买入445.14万元，融资偿还171.29万元，融资净买入273.85万元，连续3日净买入累计390.16万元。融券方面，融券卖出700.0股，融券偿还0.0股，融券余量41.12万股，融券余额93.34万元。海王生物主营业务：涵盖医药商业流通、医药制造、医药研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600013778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0028","BK0168","BK0188","000078","BK0209"],"gpt_icon":0},{"id":"2444272344","title":"海王生物：公司将密切跟进相关事项的进展，并督促相关方按照有关规定及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2444272344","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444272344?lang=zh_cn&edition=full","pubTime":"2024-06-19 19:02","pubTimestamp":1718794949,"startTime":"0","endTime":"0","summary":"证券之星消息，海王生物(000078)06月19日在投资者关系平台上答复投资者关心的问题。投资者：公司的重大事项能不能完成，两年多了海王生物董秘：您好，感谢您的关注。公司将密切跟进相关事项的进展，并督促相关方按照有关规定及时履行信息披露义务。谢谢！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061900036948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0209","BK0188","000078","BK0168","BK0060"],"gpt_icon":0},{"id":"2444116571","title":"海王生物（000078）股东深圳海王集团股份有限公司质押6362.5万股，占总股本2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444116571","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444116571?lang=zh_cn&edition=full","pubTime":"2024-06-18 03:26","pubTimestamp":1718652374,"startTime":"0","endTime":"0","summary":"证券之星消息，海王生物6月18日公开信息显示，股东深圳海王集团股份有限公司向中信银行股份有限公司深圳分行合计质押6362.5万股，占总股本2.31%。质押详情见下表：截止本公告日，股东深圳海王集团股份有限公司已累计质押股份12.14亿股，占其持股总数的99.83%。海王生物主营业务：涵盖医药商业流通、医药制造、医药研发。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061800002964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0188","BK0060","BK0028","BK0209","000078"],"gpt_icon":0},{"id":"2441479191","title":"海王生物：公司没有研发抗核辐射药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2441479191","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441479191?lang=zh_cn&edition=full","pubTime":"2024-06-06 18:04","pubTimestamp":1717668288,"startTime":"0","endTime":"0","summary":"证券之星消息，海王生物(000078)06月06日在投资者关系平台上答复投资者关心的问题。投资者：请问贵公司有研发自己的抗核辐射药物吗？日本核污染海洋，未来生物医学研究方向一定要预防抗辐射药物为人体带来抵抗作用的药品。海王生物董秘：您好，感谢您的关注。公司没有研发抗核辐射药物。谢谢！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060600036898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0028","BK0060","BK0188","BK0209","000078"],"gpt_icon":0},{"id":"2440210099","title":"海王生物（000078）5月31日主力资金净买入1101.71万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440210099","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440210099?lang=zh_cn&edition=full","pubTime":"2024-06-03 09:12","pubTimestamp":1717377137,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月31日收盘，海王生物报收于2.35元，上涨5.86%，换手率1.28%，成交量33.73万手，成交额7868.29万元。近5日资金流向一览见下表：海王生物融资融券信息显示，融资方面，当日融资买入596.71万元，融资偿还599.57万元，融资净偿还2.87万元。海王生物主营业务：涵盖医药商业流通、医药制造、医药研发。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060300000910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0028","BK0060","BK0188","BK0209","000078"],"gpt_icon":0},{"id":"2439687614","title":"海王生物最新公告：重大事项尚处于筹划阶段 尚未签署正式协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2439687614","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439687614?lang=zh_cn&edition=full","pubTime":"2024-05-30 18:51","pubTimestamp":1717066271,"startTime":"0","endTime":"0","summary":"海王生物公告，截至本公告披露日，本次重大事项尚未签署正式协议，该事项尚需履行必要的决策、审批程序。公司将继续严格按照有关法律法规及规范性文件的要求，根据重大事项的进展情况及时履行信息披露义务。本次重大事项尚存在重大不确定性，敬请广大投资者知悉并注意投资风险。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024053000033475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0209","BK0188","000078","BK0168","BK0060"],"gpt_icon":0},{"id":"2433374144","title":"海王生物：公司将根据新药研发情况及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2433374144","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433374144?lang=zh_cn&edition=full","pubTime":"2024-05-08 19:02","pubTimestamp":1715166170,"startTime":"0","endTime":"0","summary":"证券之星消息，海王生物05月08日在投资者关系平台上答复投资者关心的问题。请问董秘目前有多少资金投入海王生物董秘：您好，感谢您的关注。公司将根据新药研发情况及时履行信息披露义务。公司2023年度研发投入金额约为6,259.57万元。公司医药制造以及医药研发的详细内容请关注公司在指定信息披露媒体上披露的《2023年年度报告》中的相关章节。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800034101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0028","BK0060","BK0188","BK0209","000078"],"gpt_icon":0},{"id":"2431965391","title":"海王生物(000078)3月31日股东户数13.85万户，较上期减少1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431965391","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431965391?lang=zh_cn&edition=full","pubTime":"2024-04-30 17:18","pubTimestamp":1714468719,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海王生物披露，截至2024年3月31日公司股东户数为13.85万户，较12月31日减少1657.0户，减幅为1.18%。在医药商业行业个股中，海王生物股东户数高于行业平均水平，截至3月31日，医药商业行业平均股东户数为3.9万户。从股价来看，2023年12月31日至2024年3月31日，海王生物区间跌幅为22.61%，在此期间股东户数减少1657.0户，减幅为1.18%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000038248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0209","BK0188","000078","BK0168","BK0060"],"gpt_icon":0},{"id":"2431807651","title":"图解海王生物一季报：第一季度单季净利润同比减42.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431807651","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431807651?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:42","pubTimestamp":1714441331,"startTime":"0","endTime":"0","summary":"证券之星消息，海王生物2024年一季报显示，公司主营收入80.88亿元，同比下降18.78%；归母净利润4264.14万元，同比下降42.79%；扣非净利润4737.23万元，同比上升6.48%；负债率86.97%，投资收益-800.76万元，财务费用1.79亿元，毛利率10.42%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000019356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000078"],"gpt_icon":0},{"id":"2431805877","title":"图解海王生物年报：第四季度单季净利润同比减53.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431805877","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431805877?lang=zh_cn&edition=full","pubTime":"2024-04-30 08:40","pubTimestamp":1714437658,"startTime":"0","endTime":"0","summary":"证券之星消息，海王生物2023年年报显示，公司主营收入364.19亿元，同比下降3.74%；归母净利润-16.9亿元，同比下降64.56%；扣非净利润-17.4亿元，同比下降58.35%；其中2023年第四季度，公司单季度主营收入77.78亿元，同比下降12.4%；单季度归母净利润-17.78亿元，同比下降53.46%；单季度扣非净利润-17.83亿元，同比下降47.12%；负债率86.94%，投资收益-4541.78万元，财务费用9.44亿元，毛利率9.76%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000016359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000078"],"gpt_icon":0},{"id":"2431877535","title":"海王生物(000078.SZ)发一季度业绩，净利润4264.14万元，同比减少42.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431877535","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431877535?lang=zh_cn&edition=full","pubTime":"2024-04-30 08:05","pubTimestamp":1714435519,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海王生物(000078.SZ)发布2024年第一季度报告，报告期内公司实现营业收入80.88亿元，同比减少18.78%;归属于上市公司股东的净利润4264.14万元，同比减少42.79%;归属于上市公司股东扣除非经常性损益净利润4737.23万元，同比增长6.48%;基本每股收益0.0162元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116001.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000078"],"gpt_icon":0},{"id":"2429349004","title":"海王生物最新公告：子公司拟投建海王智慧医药物流园","url":"https://stock-news.laohu8.com/highlight/detail?id=2429349004","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429349004?lang=zh_cn&edition=full","pubTime":"2024-04-24 19:30","pubTimestamp":1713958250,"startTime":"0","endTime":"0","summary":"海王生物公告，为满足公司未来经营发展的需要，公司全资子公司山东银河拟与潍坊高新技术产业开发区管理委员会签署《海王智慧医药物流园项目合同书》，以招拍挂方式取得新地块（具体价格以实际成交价格为准），计划首期投资2.98亿元建设公司智能化医药物流中心。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400040641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","000078","BK0209","BK1515","BK1161","09939","BK0168","BK0060","BK0028","BK0188","BK1574"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1998-12-18","address":"广东省深圳市南山区科技中三路1号海王银河科技大厦24层","stockEarnings":[{"period":"1week","weight":-0.052},{"period":"1month","weight":0.1806},{"period":"3month","weight":0.1435},{"period":"6month","weight":-0.1356},{"period":"1year","weight":-0.1981},{"period":"ytd","weight":-0.1879}],"companyName":"深圳市海王生物工程股份有限公司","boardCode":"AI0052","perCapita":"18965股","boardName":"零售业","registeredCapital":"275083万元","compareEarnings":[{"period":"1week","weight":-0.0307},{"period":"1month","weight":-0.0275},{"period":"3month","weight":-0.064},{"period":"6month","weight":-0.0066},{"period":"1year","weight":-0.1013},{"period":"ytd","weight":-0.0282}],"survey":"　　深圳市海王生物工程股份有限公司主营业务是生物制品、生化制品、海洋药物、海洋生物制品、中成药的生产销售。主要产品是抗肿瘤、麻醉精神类药、肠外营养药、基础输液类、现代中成药、中成药、化药。","serverTime":1722021982290,"listedPrice":5.36,"stockholders":"138465人(较上一季度减少1.18%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海王生物(000078)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海王生物(000078)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海王生物,000078,海王生物股票,海王生物股票老虎,海王生物股票老虎国际,海王生物行情,海王生物股票行情,海王生物股价,海王生物股市,海王生物股票价格,海王生物股票交易,海王生物股票购买,海王生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海王生物(000078)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海王生物(000078)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}